Metraipolis › archive › dc_a490da9c67fe
Frailty and functional outcomes in patients with progressive fibrosing interstitial lung diseases receiving antifibrotic therapy: a real-life observational… — Europe PMC PMID:41767539
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41767539
- DOI
- 10.3389/fmed.2026.1741725
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T20:38:25.797Z
- SHA-256 of the archived text
502b3452ba3d906394a4c1064859e3c6c4502e9294f7dad3589210b1980a4c98- Stable URL of this page
https://metraipolis.com/documento/dc_a490da9c67fe
How to cite
Frailty and functional outcomes in patients with progressive fibrosing interstitial lung diseases receiving antifibrotic therapy: a real-life observational… — Europe PMC PMID:41767539 — Europe PMC (en), https://europepmc.org/article/MED/41767539 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a490da9c67fe (Metraipolis archive dc_a490da9c67fe, sha256 502b3452ba3d906394a4c1064859e3c6c4502e9294f7dad3589210b1980a4c98)
BibTeX
@misc{dca490da9c67fe,
title = {Frailty and functional outcomes in patients with progressive fibrosing interstitial lung diseases receiving antifibrotic therapy: a real-life observational… — Europe PMC PMID:41767539},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41767539},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a490da9c67fe; sha256 502b3452ba3d906394a4c1064859e3c6c4502e9294f7dad3589210b1980a4c98},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41767539. Agents can read the archived copy with the MCP tool read_document.